Organisation paid for research Program year 2023 Source: CMS Open Payments

Digestive Disease Associates, LLC

Neither a doctor nor a teaching hospital

Research payments

$72,734

8 payments

Through program year 2023, Digestive Disease Associates, LLC is reported as receiving $72,734 in research payments, across 8 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$5,150	2
2019	Research	$67,584	6

Breakdown

Who paid Research payments · program years 2019–2023

AbbVie, Inc. $67,584 6 payments
Celgene Corporation $5,000 1 payment
Novartis Pharmaceuticals Corporation $150 1 payment

Studies the money was for Research payments · program years 2019–2023

B16-439 $61,285 2 payments
M14-222 $6,299 4 payments
Phase III CC-93538 Treat-Through (CC-93538-EE-001) Wk24 PE Primary - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolesc $5,000 1 payment
A Randomized Double Blind Placebo Controlled 2 Part Adaptive Design Multicenter 12 Week Study to Assess Safety Tolerability and Efficacy of Ljn452 in Patients With Non Alcoholic Steatohepetatis Nash $150 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.